Literature DB >> 9740201

Bacterial wall lipopolysaccharide as a cause of intussusception in mice.

Z Lin1, P Cohen, A Nissan, T M Allweis, H R Freund, M Hanani.   

Abstract

BACKGROUND: There is evidence that intussusception is associated with bacterial infection. It was hypothesized that a component of the bacterial wall may induce the intussusception. This study was intended to determine whether lipopolysaccharide from Escherichia coli or Salmonella can initiate intussusception in mice.
METHODS: Lipopolysaccharide was injected intraperitoneally in mice, and the animals were examined for the presence of intussusception from 2 to 192 hours after injection. Gastrointestinal transit was assessed by measuring the passage of charcoal in the small intestine. Transit index was defined as the ratio between the distance traveled by charcoal and the total length of the small intestine.
RESULTS: Intussusceptions were found in as much as 25.9% of lipopolysaccharide-injected animals, whereas in control animals, the incidence was zero. The threshold for the lipopolysaccharide effect was at 4 mg/kg and incidence reached a plateau at 8 mg/kg to 16 mg/kg. The incidence of intussusception peaked 6 hours after injection of lipopolysaccharide and declined to zero after 15 hours. To test the possibility that lipopolysaccharide induces intussusception by altering motility, its effect on transit index was measured. A dose of 12 mg/kg lipopolysaccharide reduced the transit index from 56.2+/-1.4% to 37.7+/-2.1% (p < 0.05). No microscopic histologic changes were found in the bowels with intussusception.
CONCLUSIONS: Intraperitoneal bacterial wall lipopolysaccharide causes intussusception in mice by disturbing gastrointestinal motility.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740201     DOI: 10.1097/00005176-199809000-00006

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

1.  Role of innate immunity and altered intestinal motility in LPS- and MnCl2-induced intestinal intussusception in mice.

Authors:  Kristin E Killoran; Amber D Miller; Karen S Uray; Norman W Weisbrodt; Robia G Pautler; Sanna M Goyert; Nico van Rooijen; Margaret E Conner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-09       Impact factor: 4.052

2.  Intussusception associated with bacterial meningitis.

Authors:  E Crushell; O Flanagan; M Devins; K Dunne; J Gleeson
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

3.  Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model.

Authors:  Kelly L Warfield; Sarah E Blutt; Sue E Crawford; Gagandeep Kang; Margaret E Conner
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

4.  Prevention of lipopolysaccharide-induced intussusception in mice by the COX2 inhibitor rofecoxib.

Authors:  Mahmoud Badriyyah; Haggi Mazeh; Stefan Brocke; Venera Osmanova; Herbert R Freund; Menachem Hanani
Journal:  Pediatr Surg Int       Date:  2007-11-06       Impact factor: 1.827

5.  Role of nitric oxide and cyclooxygenase pathway in lipopolysaccharide-induced intussusception.

Authors:  Zafer Türkyilmaz; Ramazan Karabulut; Sebnem Gülen; Billur Demiroğullari; I Onur Ozen; Kaan Sönmez; A Can Başaklar; Nuri Kale
Journal:  Pediatr Surg Int       Date:  2004-08-26       Impact factor: 1.827

6.  Intussusception complicating typhoid fever.

Authors:  V Raveenthiran; P V Hayavadana Rao; M Murugesan
Journal:  J R Soc Med       Date:  2005-08       Impact factor: 18.000

7.  Increased proportion of nitric oxide synthase immunoreactive neurons in rat ileal myenteric ganglia after severe acute pancreatitis.

Authors:  Zhong Lin; Ying Liu; Qinghua Zheng; Qinghua Hu
Journal:  BMC Gastroenterol       Date:  2011-11-23       Impact factor: 3.067

8.  The impact of social distancing during the COVID-19 pandemic on rates of pediatric idiopathic intussusception.

Authors:  Atsuhiko Handa; Michael J Callahan; Kosuke Kawai; Andy Tsai
Journal:  Pediatr Radiol       Date:  2021-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.